Why is Indrayani Biotec falling/rising?

As of 18-Sep, Indrayani Biotech Ltd's stock price is currently at 11.75, reflecting a decrease of 0.15, or 1.26%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 51.29% against the 5-day average. The company has reported negative results for the last five consecutive quarters, with a substantial decline in both profit before tax and profit after tax. Furthermore, the stock has shown a staggering year-to-date decline of 67.70% and a one-year decline of 73.06%, highlighting its consistent underperformance compared to the benchmark.
In the broader market context, the stock's performance over the past week has been notably poor, with a return of -3.92%, while the Sensex has gained 1.80% during the same period. This underperformance is further exacerbated by a weak long-term fundamental outlook, characterized by a -253.18% CAGR growth in operating profits over the last five years and a high debt-to-EBITDA ratio of 7.34 times. Institutional investors have also reduced their stakes, indicating a lack of confidence in the company's future prospects. Overall, the combination of weak financial performance, declining investor interest, and significant underperformance against the benchmark contributes to the stock's downward movement.